Correlative study between C-reactive protein, clinical severity, and nerve conduction studies in Guillain-Barrè syndrome
Tóm tắt
Từ khóa
Tài liệu tham khảo
Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27:21–4.
Chen AC, Chen CM, Chang HR, Yeo KJ, Tsao SM, Hsiao PC, Tsai SJ. Complicated acute motor axonal neuropathy with delayed acute respiratory distress syndrome and rapidly progressive glomerulonephritis: a case report. Acta Neurol Taiwanica. 2013;22(1):26–31.
Chiò A, Cocito D, Leone M, Giordana MT, Mora G, Mutani R. Guillain–Barré syndrome: a prospective, population based incidence and outcome survey. Neurology. 2003;60:1146–50.
Daniel S. Guillain Barré syndrome: Anaethesia tutorial of the week 238. ATOTW. 2011;238:2–8.
Dhadke SV, Dhadke VN, Bangar SS, Korade MB. Clinical profile of Guillain Barre syndrome. J Assoc Physicians India. 2013;61:168–72.
Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014;137:33–43.
González-Suárez I, Sanz-Gallego I, Arpa J. Guillain-Barré syndrome: natural history and prognostic factors: a retrospective review of 106 cases. BMC Neurol. 2013;13:95.
Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis. 1997;176(2):92–9.
Kalita J, Misra UK. Guillain-Barré syndrome: subtypes and predictors of outcome from India. JPNS. 2014;19:36–43.
Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines. Molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol. 2005;288:2031–41.
Levesque R. SPSS programming and data management: a guide for SPSS and SAS users. 4th ed. Chicago: SPSS Inc.; 2007.
Lobo SM. Sequential C-reactive protein measurements in patients with serious infections: does it help? Crit Care. 2012;16:130–1.
Mohamed NM, Magzoub MSM, Osman AA, Abdalla NM. Clinical and epidemiological study on inflammatory polyneuropathy (Guillain-Barré syndrome) among Sudanese cases. Int J Clin Med Res. 2016;3(1):1–5.
Newswanger DL, Warren CR. Guillain Barré syndrome. Am Fam Physician. 2004;69(10):2405–10.
Ortiz-Corredor F, Pena-Preciado M, Diaz-Ruitz J. Motor recovery after Guillain-Barré syndrome in childhood. Disabil Rehabil. 2007;29:883–9.
Parmar LD, Doshi V, Singh SK. Nerve conduction studies in Guillian Barré syndrome. Int J Neurol. 2013;16(1):1–14.
Peaceman AM, Andrews WW, Thorp JM. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol. 1997;177:13–8.
Rajabally YA, Uncini A. Outcome and its predictors in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 2012;83:711–8.
Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain–Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36:123–33.
Sudulagunta SR, Sodalagunta MB, Sepehrar M, Khorram H, Raja SKB, Kothandapani S, Noroozpour Z, Sham MA, Prasad N, Sunny SP, Mohammed MD, Gangadharappa R, Sudarshan RN. Guillain –Barré syndrome: clinical profile and management. GMS. 2015;13:1612–3174.
Szalai AJ. C-reactive protein and autoimmune disease. Facts and conjectures. Clin Dev Immunol. 2004;11:221–6.
Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barre syndrome: a critical revision and the need for an update. J Int Fed Clin Neurophysiol. 2012;123(8):1487–95.
Vaishnavi C, Kapoor P, Behura C, Singh SK, Prabhakar S. C-reactive protein in patients with Guillain Barre syndrome. Indian J Path Microbiol. 2014;57(1):51–4.
Walling AD, Dickson G. Guillain-Barre syndrome. Am Fam Physician. 2013;87(3):191–7.
Yu RK, Usuki S, Ariga T. Ganglioside molecular mimicry and its pathological roles in Guillain Barré syndrome and related diseases. Infect Immun. 2006;74:6517–27.